What are the side effects of Trintellix (vortioxetine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of Trintellix (Vortioxetine)

The most common side effects of Trintellix are nausea, constipation, and vomiting, with nausea being dose-related and typically occurring within the first week of treatment before decreasing in frequency. 1

Most Common Side Effects

  • Nausea is the predominant side effect and is dose-dependent, commonly appearing within the first week of treatment, then decreasing in frequency but potentially persisting in some patients 1, 2
  • Constipation and vomiting are the other most frequently reported gastrointestinal effects 1
  • Additional common side effects include diarrhea, dry mouth, dizziness, and headache 3
  • These gastrointestinal and general side effects are consistent with the broader class of second-generation antidepressants 4

Sexual Dysfunction

  • Vortioxetine can cause sexual problems in both males and females 1
  • In males: delayed ejaculation or inability to ejaculate, problems achieving or maintaining erection, and decreased sex drive 1
  • In females: decreased sex drive and delayed or absent orgasm 1
  • Patients should be counseled to discuss any changes in sexual function with their provider, as management strategies may be available 1
  • Notably, vortioxetine may actually be beneficial for patients who experienced sexual dysfunction on other antidepressants, particularly SSRIs like paroxetine 5

Serious Side Effects Requiring Immediate Attention

Serotonin Syndrome

  • A potentially life-threatening condition that requires emergency care 1
  • Symptoms include: agitation, hallucinations, confusion, coma, rapid heart rate, blood pressure changes, dizziness, sweating, flushing, hyperthermia, tremors, muscle stiffness or twitching, loss of coordination, seizures, and gastrointestinal symptoms (nausea, vomiting, diarrhea) 1
  • Risk increases when combined with other serotonergic medications including triptans, SSRIs, SNRIs, tricyclic antidepressants, lithium, tramadol, fentanyl, other opioids, tryptophan, buspirone, and St. John's Wort 1

Bleeding Risk

  • Increased bleeding risk, particularly when combined with aspirin, NSAIDs, warfarin, or other blood thinners 1
  • Patients should report any unusual bleeding or bruising immediately 1

Hyponatremia

  • Low sodium levels can occur and may be serious or fatal 1
  • Elderly patients and those taking diuretics are at higher risk 1
  • Symptoms include: headache, difficulty concentrating, memory changes, confusion, weakness, and unsteadiness leading to falls 1
  • Severe cases may present with hallucinations, fainting, seizures, coma, or respiratory arrest 1

Angle-Closure Glaucoma

  • Vortioxetine can cause mild pupillary dilation, which may trigger angle-closure glaucoma in susceptible individuals 1
  • Patients with pre-existing risk factors should consider prophylactic eye examination and treatment (e.g., iridectomy) 1
  • Seek immediate care for eye pain, vision changes, or swelling/redness around the eye 1

Psychiatric Side Effects

Activation of Mania/Hypomania

  • Manic episodes can occur in patients with bipolar disorder 1
  • Warning signs include: greatly increased energy, racing thoughts, grandiose ideas, rapid or excessive talking, severe insomnia, reckless behavior, and excessive happiness or irritability 1

Suicidality

  • Increased risk of suicidal thoughts and actions in patients under age 24, especially during the first few months of treatment or with dose changes 1
  • Close monitoring is essential for new or sudden changes in mood, behavior, thoughts, or feelings 1
  • This risk is consistent with the broader class of SSRIs, which are associated with increased nonfatal suicide attempts (odds ratio 2.25,95% CI 3.3-4.6) 4

Discontinuation Syndrome

  • Abruptly stopping Trintellix can cause serious withdrawal symptoms 1
  • The dose should be tapered gradually under physician supervision 1
  • Discontinuation symptoms include: nausea, sweating, mood changes, irritability, agitation, dizziness, paresthesias (electric shock sensations), tremor, anxiety, confusion, headache, fatigue, insomnia, hypomania, tinnitus, and seizures 1

Pregnancy and Breastfeeding Considerations

  • Trintellix may cause neonatal withdrawal symptoms or persistent pulmonary hypertension of the newborn (PPHN) when taken during the third trimester 1
  • Pregnant women or those planning pregnancy should discuss risks versus benefits with their provider 1
  • A pregnancy registry exists for monitoring outcomes (National Pregnancy Registry for Antidepressants: 1-844-405-6185) 1
  • It is unknown whether vortioxetine passes into breast milk 1

Clinical Tolerability Profile

  • Vortioxetine is generally well tolerated with side effects typically mild to moderate in severity 5, 2
  • In direct comparison to duloxetine, vortioxetine demonstrated lower risk of common antidepressant-induced adverse effects, though with slightly smaller efficacy 3
  • The overall safety profile is comparable to existing first-line antidepressants 2
  • Nausea and vomiting are the most common reasons for treatment discontinuation in clinical trials 4, 6

Drug Interactions Requiring Caution

  • Contraindicated with MAOIs (including linezolid and IV methylene blue) - do not use within 14 days of stopping an MAOI, and wait 21 days after stopping Trintellix before starting an MAOI 1
  • Medications requiring careful monitoring include those affecting serotonin, bleeding risk, or metabolized by CYP2D6 1
  • Strong CYP2D6 inhibitors (like bupropion) may require dose adjustment 7

References

Research

Vortioxetine: a New Treatment for Major Depressive Disorder.

Expert opinion on pharmacotherapy, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Side Effects of New Antidepressants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.